Navigation Links
An analysis of the surgical and perioperative complications in right hepatectomies
Date:9/17/2008

Adult living related liver donors play an essential role in filling the gap of transplants needed due to a heavy shortage of cadaveric donations. Considering that living related donors are healthy individuals at baseline, it is imperative to ensure good outcomes and return to quality of life.

A research article to be published on 28 May 2008, in the World Journal of Gastroenterology addresses this question. The research team led by Prof. Salvatore Gruttadauria from Istituto Mediterraneo Trapianti e Terapie ad Alta Specializzazione designed an accurate, comprehensive step-by-step work-up protocol for donor evaluation to ensure donor safety and to confirm that the donor is capable of providing a suitable graft.

The strategy of careful evaluation of the living donor performed by an interdisciplinary team cannot be overemphasized. Their research has proven the necessity of evaluating the overall health of both the donor and recipient at many different levels from biopsy to body mass index. Their research has indicated liver biopsy in the exclusion of potential donors otherwise considered fit to donate. These biopsies assess the quality of the donation to ensure the likelihood of success of the transplant and the health of both the donor and the recipient.

Authors' experience shows that heavier donors, when subjected to an exercise and diet program, all return to previous activity. In fact, no life threatening complications, long term impairments, or deaths have occurred in these donors.

With all of this in mind, the study was designed to evaluate operative complications in a series of seventy five patients. In heir series, 30.6% of living donors developed a complication in the perioperative period. Complications related to biliary tree reconstruction (9.33%) were the most common, although no patients had to undergo repeated open surgery. None of the 75 live donors in the series, regardless of their post-operative course,
'/>"/>

Contact: Lai-Fu Li
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Advanced blood analysis may speed diagnosis of heart attacks
2. San Francisco Bay Area Cell Analysis Company Forges Partnership With Hudson Control Group as First Step in Automation Initiative to Support Drug Discovery Research
3. ProSanos Corporation Releases New Software System to Improve Patient Safety via Surveillance and Analysis of Claims and Electronic Health Records
4. Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads
5. Kansas Health Policy Authority Awards Thomson Reuters Contract for Health Care Data Integration and Analysis Initiative
6. Next generation data analysis for next generation sequencing data
7. Analysis of cancer incidence, mortality and survival combined reveals encouraging European trends
8. Caris Diagnostics Providing KRAS Mutational Analysis for Colon Cancer Patients
9. The DataTrace(R) RF System, the Latest High Performance Radio Data Logger for Real-Time, Process Data Collection, Reporting, and Analysis Is Launched
10. Patient Data Analysis Report Finds More Than 75 Percent of Chronically Ill Patients Unable to Obtain Needed Healthcare Have Some Form of Insurance
11. Analysis of Millions of U.S. Births Shows Association Between Birth Defects and Preterm Birth

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... legislation would strengthen Medicare, improve co...PRNewswire-USNewswire/ -- SUMMARY: Yesterday the...tical health care reform legislation that would st...on by insurance companies that prices millions of ..., The Affordable Health Care for America Act (H.R...
(Date:11/8/2009)... UCW Academy of Health holds open house ...oria, BC (Vocus) November 8, 2009 -- UCW Academy o...in British Columbia’s health care industry t..., November 25, 2009. , ,UCW Academy of Health, wh...n, nursing and social services, designs its progra...
(Date:11/8/2009)...N, Nov. 7 Tonight the H...th Care for America Act, landmark health reform le...ss to quality, affordable, stable and secure healt...n on some of the insurance industry,s worst practi... and cut the deficit by $104 billion over ten year...
(Date:11/8/2009)... Men’s Health Network (MHN) urges ...s, especially those linked to exposure to chemical...ervice. Bladder cancer is one of those cancers tha...lly those who once smoked or currently smoke cigar...RWEB) November 8, 2009 -- Men’s Health Netwo...
(Date:11/8/2009)... largest network of Hispanic health advocates comm...n 2009 ,, WASHINGTON, Nov. 7 /PRNewswire-USNew...es showed they have heard the voice of America,s f...America Act. Now the Senate must deliver, without ...form," said Dr. Jane L. Delgado, President and CEO...
Breaking Medicine News(10 mins):Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2
...ratures mean more ozone, and more strain on hearts...HealthDay News) -- Soaring temperatures and high o...m heart disease and stroke, researchers report. , ...s. , "Temperature and ozone are strong factors in ...
...,S PICK: Pregnant women pass on the effects of smo...rse effects on fetal development. A new study in m...versity of Toronto, Canada, now adds the possibili...egative outcomes. , , The authors found that fema...
...HIA Researchers from the Abramson Cancer Center o...hat findings from two large, international clinica...with multiple myeloma, a cancer that occurs in the...patients significantly improved by all measures wh...
...ANCISCO, Calif., Nov. 21 Rigel,Pharmaceuticals, I...host a,conference call with simultaneous webcast t...y of R788, a novel, oral Syk kinase inhibitor, in,...ment and the principal investigator on the study, ...
...C., Nov. 21 The National Business Coalition,on He...South Carolina an,eValue8 Health Plan Innovation A...he award recognizes programs that address critical...nt and,continuity of care for members with severe ...
...v. 21 Flagship Global Health,Inc. ("Flagship") (O...f,John Flood as its new Chief Executive Officer. C... of Flagship. Mr. Flood has been President of,Flag...s on the strategic direction of the Company., "Ha...
Other Medicine News:Health News:Global Warming May Trigger Rise in Heart Deaths 2Health News:Global Warming May Trigger Rise in Heart Deaths 3Health News:JCI table of contents: Nov. 21, 2007 2Health News:JCI table of contents: Nov. 21, 2007 3Health News:JCI table of contents: Nov. 21, 2007 4Health News:JCI table of contents: Nov. 21, 2007 5Health News:JCI table of contents: Nov. 21, 2007 6Health News:JCI table of contents: Nov. 21, 2007 7Health News:JCI table of contents: Nov. 21, 2007 8Health News:JCI table of contents: Nov. 21, 2007 9Health News:JCI table of contents: Nov. 21, 2007 10Health News:Penn's Abramson Cancer Center part of major phase III study for myeloma 2Health News:Penn's Abramson Cancer Center part of major phase III study for myeloma 3Health News:Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in ITP 2Health News:Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in ITP 3Health News:Business Coalition Honors BlueChoice HealthPlan for Migraine Program 2Health News:John H. Flood III Named as CEO of Flagship Global Health, Inc. 2
(Date:11/6/2009)...wswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. ...previously approved reverse split of its common st...nday, Nov. 9, 2009 on a 1-for-15 split-adjusted ba...e under the new symbol OXBT. The stock also will h...t becomes effective. ,, "This reverse split was...
(Date:11/6/2009)... Pa., Nov. 6 In consultation with ...l Consumer Healthcare, Division of McNEIL-PPC, Inc...umber of product lots of TYLENOL® Arthritis P... red EZ-OPEN CAP. McNeil is initiating the recall ...te associated with these lots that led to a small ...
(Date:11/6/2009)...ire/ -- Trius Therapeutics, Inc. announced today t...S-1 with the U.S. Securities and Exchange Commissi...ering of shares of its common stock. All shares of...be offered by the Company. ,, Credit Suisse Sec...anager, Piper Jaffray & Co. is acting as co-le...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 50901 1Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 50901 2Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 50901 3HMS Awarded Third Party Data Match and Recovery Contract by Mississippi Medicaid 50897 1Fortune Recognizes Female Health Company as One of Americas Fastest Growing Small Companies 50895 1Fortune Recognizes Female Health Company as One of Americas Fastest Growing Small Companies 50895 2Fortune Recognizes Female Health Company as One of Americas Fastest Growing Small Companies 50895 3Fortune Recognizes Female Health Company as One of Americas Fastest Growing Small Companies 50895 4
...IANAPOLIS, Sept. 20 Eli Lilly and Company,(NYSE: ...plication with the,European Medicines Agency (EMEA...for injection), in combination with cisplatin, for...ll lung cancer (NSCLC). ALIMTA is currently indic...ingle agent for the treatment of patients with loc...
...When compared to insulin glargine, exenatide offer...ta-cell function when used with metformin --, AMS...als, Inc. (Nasdaq: AMLN ) and Eli Lilly and Compa...paring treatment of exenatide injection,with insul...l and weight in,people with type 2 diabetes. Study...
Other Medicine Technology:Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 2Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 3Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 4Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 5Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 6Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 7Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 8Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 9Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 10Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 11Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 12One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 2One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 3One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 4One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 5One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 6One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 7
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: